The only thing that stays the same is that everything changes. This is true even when it comes to nonsterile compounding and USP <795>. PCCA Clinical Compounding Pharmacist Matt Martin, PharmD, addresses notable changes of the new USP guidelines and provides some considerations regarding implementation.

Eagle's own Dylan Herr, discusses how the sanitary conditions for sterile and non-sterile drugs at compounding facilities are regulated and how those regulations can affect you.